ABDOMINAL SCINTIGRAPHY USING TC-99M-HMPAO-LABELED LEUKOCYTES IN PATIENTS WITH SERONEGATIVE SPONDYLARTHROPATHIES WITHOUT CLINICAL-EVIDENCE OF INFLAMMATORY BOWEL-DISEASE
Jc. Alonso et al., ABDOMINAL SCINTIGRAPHY USING TC-99M-HMPAO-LABELED LEUKOCYTES IN PATIENTS WITH SERONEGATIVE SPONDYLARTHROPATHIES WITHOUT CLINICAL-EVIDENCE OF INFLAMMATORY BOWEL-DISEASE, European journal of nuclear medicine, 23(3), 1996, pp. 243-246
Abdominal scintigraphy with technetium-99m hexamethylpropylene amine o
xime (Tc-99m-HMPAO)-labelled leucocytes is an excellent tool for evalu
ating disease extent and activity of intestinal lesions in patients wi
th inflammatory bowel disease (IBD). In some cases of seronegative spo
ndylarthropathies (SSp), IBD may remain subclinical. The aim of this s
tudy was to evaluate the presence of positive abdominal scintigraphy i
n patients with SSp and without clinical symptoms or signs of IBD, To
this end we studied 32 patients with active SSp (European Spondylarthr
opathy Study Group 1991 criteria) without clinical evidence of IBD (ei
ght had ankylosing spondylitis, four psoriatic arthritis, three reacti
ve arthritis an 17 undifferentiated SSp) and 11 controls without SSp.
All SSp and control patients received similar doses of non-steroidal a
nti-inflammatory drugs (NSAIDs), Abdominal scintigraphic images were o
btained at 30 and 120 min after re-injection of Tc-99m-HMPAO-labelled
leucocytes. The Tc-99m-HMPAO-labelled leucocyte scan was positive in 1
7 patients with SSp (53.1%) (six with ankylosing spondylitis, three wi
th psoriatic arthritis, two with reactive arthritis and six with undif
ferentiated SSp). Fourteen patients scored from 2 to 4 on the intensit
y of uptake scale. The colon and terminal ileum were predominantly inv
olved. Axial involvement was more frequent in patients with a positive
scan than in patients with negative results (P < 0.05) (64.7% vs 26.6
%; odds ratio: 5). No control patient showed a positive scan. It is co
ncluded that Tc-99m-HMPAO-labelled leucocyte scan shows increased upta
ke among patients with SSp without evidence of IBD. These findings pro
vide new evidence linking SSp with intestinal inflammation and suggest
that in some cases a bowel-related process could contribute to the de
velopment of SSp. Longterm follow-up studies with more patients are ne
cessary to evaluate the diagnostic and therapeutic implications of the
se results.